Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
r9K3ru6Xna3VA8Nr